January 2020; 7 (1) Correction
A case of idiopathic multicentric Castleman disease in an alemtuzumab-treated patient with MS
First published December 5, 2019, DOI: https://doi.org/10.1212/NXI.0000000000000657
A case of idiopathic multicentric Castleman disease in an alemtuzumab-treated patient with MS
Neurol Neuroimmunol Neuroinflamm Jan 2020, 7 (1) e657; DOI: 10.1212/NXI.0000000000000657
Citation Manager Formats
Make Comment
See Comments
See original article:

Article Information
vol. 7 no. 1 e657
PubMed:
Online ISSN:
History:
- First Published December 5, 2019.
Copyright & Usage:
© 2019 American Academy of Neurology
Author Disclosures
Article usage
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.